Pennsylvania 2025-2026 Regular Session

Pennsylvania Senate Bill SB1126

Introduced
12/29/25  

Caption

In casualty insurance, providing for coverage for epinephrine delivery systems.

Impact

The legislation's enactment would significantly affect state laws related to casualty insurance, specifically ensuring that policies cover epinephrine delivery systems as a standard provision. It would compel insurance companies to adapt their offerings to comply with this requirement, which may involve adjusting their policy structures, premiums, and out-of-pocket expenses for policyholders. The bill seeks to alleviate financial burdens related to emergency allergic reactions, thereby enhancing public health and safety by ensuring that necessary medical devices are readily accessible during critical times.

Summary

SB1126 proposes to amend current casualty insurance regulations to ensure coverage for epinephrine delivery systems. This bill is set against the backdrop of increasing concerns regarding allergic reactions and the critical need for access to life-saving medications like epinephrine for individuals with severe allergies. By mandating insurance coverage for these delivery systems, the bill aims to improve health outcomes and accessibility for vulnerable populations in emergency situations. This initiative is particularly vital for families and individuals who may face high out-of-pocket costs for these essential medical devices.

Contention

While supporters of SB1126 laud its intent to safeguard individuals against potentially life-threatening allergic reactions, some critics argue that mandating coverage could lead to increased insurance premiums for consumers. There are concerns that insurance providers may respond to the requirement by raising costs across the board, which could negate the intended affordability that the bill aims to achieve. Additionally, some health policy experts have raised questions regarding the bill's implementation and the extent of monitoring necessary to ensure compliance among insurers.

Companion Bills

No companion bills found.

Previously Filed As

PA HB2022

In casualty insurance, providing for coverage for scalp cooling systems.

PA HB305

In casualty insurance, providing for coverage for insulin.

PA SB967

In casualty insurance, providing for coverage for dyslexia.

PA SB1211

In casualty insurance, further providing for coverage for biomarker testing.

PA HB1088

In casualty insurance, providing for coverage for blood pressure monitors.

PA HB1670

In casualty insurance, further providing for hearing aid coverage.

PA HB1519

In casualty insurance, further providing for mental illness coverage.

PA SB272

In casualty insurance, providing for infertility care coverage.

PA HB922

In casualty insurance, providing for fertility preservation coverage.

PA HB1802

In casualty insurance, providing for coverage of COVID-19 vaccines.

Similar Bills

NH HB63

Relative to the use of nasal spray to treat anaphylaxis.

TX HB2283

Relating to the use of an epinephrine delivery device by certain entities.

TX SB1619

Relating to the use of an epinephrine delivery system by certain entities.

NH HB677

Relative to the possession and use of epinephrine at recreation camps, schools, and institutions of higher education.

MI HB5051

Health: pharmaceuticals; administration of epinephrine; modify. Amends title & secs. 1, 2 & 3 of 2020 PA 312 (MCL 28.821 et seq.). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5050'25, HB 5052'25, HB 5053'25

IL HB3454

EPINEPHRINE DELIVERY DEVICE

MD HB420

Education and Health - Emergency Use Epinephrine - Alterations

MD SB459

Education and Health - Emergency Use Epinephrine - Alterations